Global Cervical Cancer Diagnostic Market (Types, Age group and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Cervical cancer refers to a malignancy of cervical cells. Vaginal bleeding is the most common symptom of this kind of cancer; however, in certain cases, no symptoms are seen until the cancer reaches an advanced stage. More than 90% of cervical malignancies occur due to HPV infection (Human papillomavirus) and they are diagnosed through smear screening. The most common types of cervical cell cancer include Squamous Cell Malignancy and Adenocarcinoma. A pin-point analysis of the global cervical cancer diagnostic market focuses on various aspects of the market such as market trends, market drivers, restraints and opportunities. The competitive landscape section focuses on key leaders within the global cervical cancer diagnostic market and their major growth strategies. A deep-dive assessment of segments identifies potential segments which would act as a guide for strategists.

A number of factors contribute to the increasing prevalence of cervical cancer, worldwide. These include rising number of female smokers, large number of patients suffering from HPV infection, growing obese population and increasing incidences of unsafe sex, particularly amongst teenagers. Cancer awareness programs also contribute to the growth of this market. HPV vaccination, inaccurate pap smear testing, ineffective healthcare infrastructure, stringent government regulations and alternative diagnosis methods are some factors, which inhibit the growth of global cervical cancer diagnostic market. Technological advances in diagnosis, aging population in developed countries and healthcare developments in emerging economies are factors which key leaders in this market could use to their advantage. 

Global Cervical Cancer Diagnostic Market by Types
 The global cervical cancer diagnostic market is segmented into three categories according to types of diagnostic tests. These categories are Pap Smear Tests, ECC Procedures and Colposcopy Tests. Pap Smear Test is the most effective tool for the diagnosis of HPV It is the sub-segment, which generates the most revenue. This is mainly due to the prevalence of HPV infection in women and the deficiency of the HPV vaccine, which does not cover all types of HPV infections.

Global Cervical Cancer Diagnostic Market by Age Group
The global cervical cancer diagnostic market is segmented into two categories based on age groups: the first category is the age group among 20-40 years and the second is the age group above 40. Cervical cancer has a varying degree of occurrence in different age groups. It can be detected at a young age due to advances in technology. Statistically adult women are most affected by the HPV infection.

Global Cervical Cancer Diagnostic Market by Geography
Geographically, the global cervical cancer diagnostic market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America dominates the global cervical cancer diagnostic market because of a rising incidence of HPV infection, rising number of women smokers, and growing aged population. Asia-Pacific is the growing market for global cervical cancer diagnostics due to government initiative and improvement in healthcare infrastructure. 

Competitive Landscape
The key players within the global cervical cancer diagnostic market include Abott Laboratories, Guided Therapeutics, Olympus, Roche, Ascon Medical Instruments, Cooper Surgical Inc, Cardinal Health, Beckman Coulter Inc. and Siemens Healthcare. There is intense competition for cervical cancer diagnostics due to the large number of cervical cancer patients. Companies are currently focusing on developing advanced techniques of diagnosis such as liquid based cytology.

High Level Analysis  
A comprehensive analysis of the global cervical cancer diagnostic market provides an overview of the market and its key concerns. The market dynamics section covers market drivers, restraints and opportunities within the global cervical cancer diagnostic market and helps in simplifying market behavior. The market is segmented in order to provide   information about niche market areas and assist in identifying potential segments. Porter’s Five Forces analysis enables the determination of profitable markets. The suppliers’ bargaining power in the global cervical cancer diagnostic market is moderate due to the existence of numerous suppliers and a large number of consumers. Also, the threat of new entrants is minimal due to strict regulatory requirements. Industrial rivalry is intense because of numerous suppliers competing for cost effective technological advances. 

KEY BENEFITS
This report offers the following benefits:

• In-depth coverage of the global cervical cancer diagnostic market including drivers, restraints and opportunities would help professionals better understand market behavior 
• Pin-point analysis of geographic segments helps to identify opportunities for growth within the global cervical cancer diagnostic market 
• Porter’s Five Forces analysis examines the competitive structure of the global cervical cancer diagnostic market and would assist market strategists
• Detailed study of the strategies of key leaders, partnerships and acquisitions in the global cervical cancer diagnostic market would be informative for professionals in corporate sector 
• The market estimates provided in the report would   enable market projections to determine the growth of the global cervical cancer diagnostics market 

  KEY DELIVERABLES

The global cervical cancer diagnostic market is segmented into three major categories: equipment, application and geography. 

MARKET BY TYPES

• Pap Smear Tests 
• ECC Procedures 
• Colposcopy Tests

MARKET BY AGE GROUP

• Age group between 20 to 40
• Age group above 40

MARKET BY GEOGRAPHY

• North America
• Europe
• Asia-Pacific
• LAMEA